Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with Dementia: I’m Still Here

vesanic dementia2 - amyloid protein1 - head injuries1 - neuropsychological tests1 - cancer1 - delirious episode1 - blast-induced traumatic brain injury1 - mental confusion4 - psychosis polyneurotica1 - mid-life stress1 - poor sleep1 - alzheimer's and parkinson's diseases1 - alzheimer disease6 - loss of balance1 - cognitive abilities1 - depression14 - alzheimer sufferer1 - behavioral problems1 - morosis1 - gastrointestinal disorders1 - alzheimer's disease symptoms1 - agnosia3 - boissier de sauvages2 - confusion3 - the gerontological society of america1 - american psychiatric association3 - dementia types1 - progression of dementia1 - dantrolene1 - physical activity2 -